{"schema_version":"secwatch.filing_event.v1","accession":"0001764046-23-000086","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.158899+00:00","generated_at":"2026-06-12T08:58:51.059431+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clarivate Q2 net loss $141.7M; revenue down 2.6%; lowers 2023 outlook","bullets":["Revenue $668.8M (-2.6% YoY); organic revenue -0.4%. Net loss $141.7M vs. income $43.7M prior year.","Adjusted EBITDA $284.9M (+3.8%), margin 42.6% (+270bps); adjusted diluted EPS $0.21 (-4.5%).","Free cash flow $104.8M (+111.6%); total debt reduced $150.5M to $4.92B.","FY2023 revenue guidance lowered to $2.685-2.745B from $2.75-2.84B; adjusted EPS to $0.83-0.86 from $0.98-1.03.","Academia & Government improved; IP and Life Sciences & Healthcare fell short of expectations."],"urls":{"canonical":"https://secwatch.observer/filing/0001764046-23-000086","json":"https://secwatch.observer/filing/0001764046-23-000086.json","markdown":"https://secwatch.observer/filing/0001764046-23-000086.md","text":"https://secwatch.observer/filing/0001764046-23-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000176404623000086/0001764046-23-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000176404623000086/clvt-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T08:58:51.059431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3455dfae82a1a406c82a707f8a5c4ac3a067e644","claim":"CLARIVATE PLC reported second quarter ended June 30, 2023 results: revenue $668.8 million, net income Net loss attributable to ordinary shares of $141.7 million, EPS Net loss per diluted share of $0.21.","evidence_excerpt":"Second Quarter 2023 Financial Highlights • Revenues of $668.8 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1764046/000176404623000086/0001764046-23-000086-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$668.8 million"},{"label":"Net income","value":"Net loss attributable to ordinary shares of $141.7 million"},{"label":"EPS","value":"Net loss per diluted share of $0.21"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}